ABSTRACT SUBMISSION
POSTER PRESENTATIONS
Poster Presentation Guidelines: Posters must be prepared in the size of 70 cm (width) × 100 cm (height). Recommended font sizes for your poster; title: bold and at least 48 pt font size, author name(s) bold and at least 36 pt font size, author affiliation(s) at least 36 pt font size. The name of the presenting author should be underlined among all listed authors (including full names and affiliations). Section headings should be written in bold and at least 24 pt font size and main text should be written in at least 24 pt font size. During the poster session hours, please wait for the judging panel members to arrive at your poster.
Code Date & Time Title Authors PP01 June 12, 2026
10:30 - 11:00Synthesis and Biological Evaluation of Some Pyrazole-urea Derivatives as Potential Antimicrobial and Antibiofilm Agents PP02 June 12, 2026
10:30 - 11:00Gas-phase Ion-molecule Reactions of Protonated Oxime Compounds with 2-Methoxypropene in a Linear Quadrupole Ion Trap Mass Spectrometer PP03 June 12, 2026
10:30 - 11:00Investigation of Bacterial and Human Topoisomerase I Inhibition Potential of Recalled Drugs by Molecular Docking Method and ADME Analyses PP04 June 12, 2026
10:30 - 11:00In Silico Evaluation of a Novel Biphenyl-Triazole Derivative as a Potential CYP51 Inhibitor: A Molecular Docking Study PP05 June 12, 2026
10:30 - 11:00Determining the Effects of Molecules with Hydrazone and Pyridazine Structures on Liver Cancer PP06 June 12, 2026
10:30 - 11:00Novel Benzazole–Benzamide Hybrids: Synthesis and In Vitro Antiproliferative Evaluation on Breast Cancer PP07 June 12, 2026
10:30 - 11:00Evaluation of Carbonic Anhydrase Enzyme Inhibitor Activities of Taurinamidobenzensulfonamide Derivatives PP08 June 12, 2026
10:30 - 11:00Analysis of Aflatoxin B1 and M1 in Medical Enteral Nutrition Products and Infant Formulas: A Chromatographic Evaluation PP09 June 12, 2026
10:30 - 11:00Synthesis and structural analysis of novel oxime ethers bearing imidazole and pyrazole rings PP10 June 12, 2026
10:30 - 11:00Virtual Screening and Molecular Dynamics-Based Evaluation of an ATP-Pocket-Targeting TNIK Hit Candidate PP11 June 12, 2026
10:30 - 11:00Thiophene-Tail Elongation of OG-001 Enhances Selective Dual Inhibition of Tumor-Associated hCA IX and XII: Molecular Dynamics Insights PP12 June 12, 2026
10:30 - 11:00Development and In Vitro Characterization of Oral Disintegrating Films Loaded with a Novel Hexahydroquinoline Compound PP13 June 12, 2026
10:30 - 11:00Laboratory-Scale Synthesis of Anhydrous Aluminum Chloride for Friedel–Crafts Applications Under Moisture-Free Conditions PP14 June 12, 2026
10:30 - 11:00Role of CD36 on Cancer and Metastasis PP15 June 12, 2026
10:30 - 11:00Anti-Cancer Effect of Oleuropein PP16 June 12, 2026
10:30 - 11:00Application of PVA Hydrogels in Drug Delivery System PP17 June 12, 2026
10:30 - 11:00Antibacterial Mechanism of Hydrogels for the Treatment of Infections PP18 June 12, 2026
10:30 - 11:00Design, Synthesis, Characterization, and Molecular Docking Studies of Novel Isatin-Based Sulfonamide Derivatives as Potential Anticancer Agents PP19 June 12, 2026
10:30 - 11:00Computer-Aided Design of RORγ (ROR Gamma) Agonist (Retinoic Acid Receptor-Related Orphan Nuclear Receptor γ) and Novel Derivatives As Therapeutic Targets In Prostate Cancer PP20 June 12, 2026
10:30 - 11:00Novel Thiazole–Acrylonitrile Derivatives: Synthesis and Evaluation as Antimicrobial Agents PP21 June 13, 2026
10:30 - 11:00Novel Benzoxazolinone Thiosemicarbazides Targeting Alzheimer’s Disease PP22 June 13, 2026
10:30 - 11:00Synthesis, Antimicrobial, and Antiproliferative Evaluation of a Novel Piperonyl-Piperazine-Hydroxypyranone Dithiocarbamate PP23 June 13, 2026
10:30 - 11:00Synthesis and Antibacterial Profiling of a Novel 3-Hydoxypyridinone Derivative PP24 June 13, 2026
10:30 - 11:00From Virtual Screening to Nanomolar Hits: Identification and Characterization of Janus Kinase 1/2 Inhibitors PP25 June 13, 2026
10:30 - 11:00Discovery of potent monoamine oxidase inhibitors: benzylidene-thiazolidinedione-acetanilide hybrids PP26 June 13, 2026
10:30 - 11:00Synthesis of New Chalcone Compounds and In Vitro Evaluation of Their Activity for Multi-Targeted Alzheimer’s Disease Therapy PP27 June 13, 2026
10:30 - 11:00Novel Flurbiprofen-Derived Hybrids with COX-1/COX-2 Inhibitory Activity PP28 June 13, 2026
10:30 - 11:00Design, synthesis, and spectroscopic characterization of thymol- and carvacrol-based hydrazone derivatives as potential antibacterial agents PP29 June 13, 2026
10:30 - 11:00Pyrano[2,3-d]pyrimidine derivatives: synthesis and evaluation of anticancer and calcium channel blocking activity PP30 June 13, 2026
10:30 - 11:00Novel Dithiocarbamate Derivatives as Potential Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Studies PP31 June 13, 2026
10:30 - 11:00Design, Synthesis, and Evaluation of 4-(4-Fluorobenzyl)-6-methylpyridazin-3(2H)-one Derivatives as Tyrosinase Inhibitors PP32 June 13, 2026
10:30 - 11:00Design, Synthesis, and Characterization of Novel Benzimidazole Derivatives for Potential FLAP Inhibition PP33 June 13, 2026
10:30 - 11:00Preparation and characterization of HNO₃-modified graphene-reinforced 2-hydroxyethyl cellulose nanocomposite hydrogels for controlled doxorubicin delivery PP34 June 13, 2026
10:30 - 11:00Synthesis and Characterization of 1-phenyl-4-(4-((2-phenylhydrazono)methyl)phenyl)piperazine Derivatives PP35 June 13, 2026
10:30 - 11:00Synthesis and Characterization of 1,3-Diphenylprop-2-en-1-one Derivatives PP36 June 13, 2026
10:30 - 11:00Graphene-Doped Electrospun Hydroxypropylcellulose (HPC) Nanofibers for Tailoring Terramycin Release Profiles PP37 June 13, 2026
10:30 - 11:00Engineering Acridine Chromophores into NIR Photosensitizers: A First-in-Class Strategy for Photodynamic Therapy PP38 June 13, 2026
10:30 - 11:00Design, Synthesis, and Structural Characterization of Novel Hybrid Compounds Containing Indanone and Tetrazole Moieties PP39 June 13, 2026
10:30 - 11:00Discovery of Novel Pyrano[3,2-b]pyran Derivatives and Evaluation of Tyrosinase Inhibitor Activity ORAL PRESENTATIONS
Oral Presentation Guidelines: Presentations should be realized by the corresponding author specified in the Abstract. Authors will be given 8 minutes for the oral presentation (+2 minutes for the discussion) and 4 minutes for the shortoral presentation (+2 minutes for the discussion). Main part of the oral presentation should involve findings, conclusion and discussion, after a brief and rapid introduction of the aim, material and methods parts. Presentation file(s) should preferably be prepared in “ppt or pptx” format, and a digital copy should be sent to the person responsible for the session (cafer@diamed98.com) no later than June 10th..
Code Date & Time Title Authors OP01 June 12, 2026
17:10 - 17:40Neuroprotective potential of Jacaranda mimosifolia in paraquat induced neurotoxicity: Anti-inflammatory, antioxidant and in-silico studies OP02 June 12, 2026
17:10 - 17:40Rational Design, ADMET Analysis, and SAR Evaluation of Pyrazole–Oxime Hybrid Compounds as Anticancer Agents against Breast Cancer OP03 June 12, 2026
17:10 - 17:40Antioxidant and immunomodulatory potential of hexahydroquinoline-3-carboxylate derivatives: in vitro and in silico studies OP04 June 13, 2026
15:10 - 15:50Biofilms across sectors: challenges and emerging antibiofilm strategies targeting quorum sensing OP05 June 13, 2026
15:10 - 15:50Comparative molecular docking and structure-activity relationship analysis of flavan-3-ols and procyanidin oligomers targeting fibrinolytic proteins OP06 June 13, 2026
15:10 - 15:50Fluoxetine Differentially Reduces Cell Viability in MYCN-Amplified and Non-Amplified Neuroblastoma Cells OP07 June 13, 2026
15:10 - 15:50Difluoromethoxy-substituted hexahydroquinolines as multi-target anti-inflammatory agents: mechanistic and metabolomic insights OP08 June 13, 2026
16:00 - 16:50A Three-Channel Orthogonal Reverse-Screening Pipeline for Target Deconvolution of Novel Chalcone-Derived Scaffolds OP09 June 13, 2026
16:00 - 16:50Design and Evaluation of Hydrogen Peroxide Activatable Photosensitizer for Brain Tumor Targeted Photodynamic Threapy OP10 June 13, 2026
16:00 - 16:50Mixed Donor Substitution in Selenium-Containing Xanthene Photosensitizers for Tuning Selectivity and Potency in PDT OP11 June 13, 2026
16:00 - 16:50Selective Lithiation Unlocks a Brominated Si-Rhodamine Based Photodynamic Therapy Agent OP12 June 13, 2026
16:00 - 16:50Enantioselective CE-MS/MS Analysis of MDMA and Major Metabolites: Comparative Pharmacokinetics in Oral Fluid, Urine and Plasma OP13 June 13, 2026
17:00 - 17:20Development of biologically active preparations based on plant raw materials OP14 June 13, 2026
17:00 - 17:20Determination of safinamide in human plasma by using liquid chromatography-tandem mass spectrometry OP15 June 13, 2026
17:00 - 17:20Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies of Novel Chlorophenylpiperazine-Hydroxypyridinone Mannich Bases OP16 June 13, 2026
17:00 - 17:20Investigation Of The Role Of mTOR Complex 2 In The Inflammatory Response And Oxidative Processes Mediating Peripheral Ischemia/Reperfusion Injury In Rats